United Therapeutics
UTHR
UTHR
332 hedge funds and large institutions have $4.21B invested in United Therapeutics in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 121 increasing their positions, 119 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
332
Holders Change
-16
Holders Change %
-4.6%
% of All Funds
6.72%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.16%
New
44
Increased
121
Reduced
119
Closed
58
Calls
$12.9M
Puts
$5.86M
Net Calls
+$7.01M
Net Calls Change
+$1.98M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$22.5M |
| 2 |
Goldman Sachs
New York
|
+$20M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.3M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$17M |
| 5 |
D.E. Shaw & Co
New York
|
+$16.1M |
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$42.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$25.3M |
| 3 |
BlackRock
New York
|
-$21.8M |
| 4 |
Two Sigma Investments
New York
|
-$18.1M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$15.5M |